Skip to main content

Tax Policy: Pharmaceutical Industry's Use of the Research Tax Credit

GGD-94-139 Published: May 13, 1994. Publicly Released: Jun 15, 1994.
Jump To:
Skip to Highlights


Pursuant to a congressional request, GAO reviewed the major tax benefits used by the pharmaceutical industry, focusing on: (1) the characteristics of the companies claiming research tax credits; and (2) whether Internal Revenue Service (IRS) tax administration efforts adequately ensure that pharmaceutical companies comply with tax credit legislation.

Full Report

Office of Public Affairs


BiotechnologyCorporationsInvestmentsPharmaceutical industryPharmacological researchResearch and developmentTax administrationTax creditTax lawTax return auditsTax shelters